Age-related macular degeneration, anti-VEGF therapy, and ophthalmic imaging: is there a best practice? JAMA Ophthalmol 2013 Sep;131(9):1124-6
Date
06/08/2013Pubmed ID
23744293DOI
10.1001/jamaophthalmol.2013.432Scopus ID
2-s2.0-84884564071 (requires institutional sign-in at Scopus site) 7 CitationsAuthor List
Han DPAuthor
Dennis Han MD Emeritus Professor in the Ophthalmology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Angiogenesis InhibitorsAntibodies, Monoclonal, Humanized
Bevacizumab
Drug Costs
Humans
Practice Guidelines as Topic
Ranibizumab
Tomography, Optical Coherence
Vascular Endothelial Growth Factor A
Wet Macular Degeneration
